Determination of ertapenem in plasma and ascitic fluid by UHPLC-MS/MS in cirrhotic patients with spontaneous bacterial peritonitis.
Autor: | Rigo-Bonnin, Raúl, Amador, Alberto, Núñez-Gárate, María, Mas-Bosch, Virgínia, Padullés, Ariadna, Cobo-Sacristán, Sara, Castellote, José |
---|---|
Předmět: |
CIRRHOSIS of the liver
PERITONITIS LIQUID chromatography-mass spectrometry HYPERLIPIDEMIA CHEMICAL reagents ERTAPENEM DESCRIPTIVE statistics STAPHYLOCOCCUS aureus ENTEROBACTERIACEAE ESCHERICHIA coli KLEBSIELLA infections WATER ELECTROSPRAY ionization mass spectrometry BACTERIAL contamination BLOOD plasma BACTERIAL diseases BODY fluids HEMOLYSIS & hemolysins DATA analysis software CALIBRATION SENSITIVITY & specificity (Statistics) TIME PHARMACODYNAMICS |
Zdroj: | Advances in Laboratory Medicine / Avances en Medicina de Laboratorio; Jun2024, Vol. 5 Issue 2, p173-180, 8p |
Abstrakt: | Spontaneous bacterial peritonitis is a frequent severe complication in cirrhotic patients with ascites. Carbapenem antibiotics are currently the treatment of choice for patients with hospital-acquired or healthcare-related infections. However, there is limited evidence available on the efficacy of ertapenem in cirrhotic patients with spontaneous bacterial peritonitis. As a result, the pharmacokynetics and pharmacodynamics of this antibiotic are still unknown. The objective of this study was to develop and validate measurement procedures based on liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) to determine ertapenem concentrations in plasma and ascitic fluid. Samples were pretreated by acetronile protein-precipitation. Chromatographic separation is performed on a C |
Databáze: | Complementary Index |
Externí odkaz: |